Infectious Diseases

Qian J, Xia J, Chiang S, Liu JF, Li K, Li F, Wei F, Aziz M, Kim Y, Go V, Morizio J, Zhong R, He[...]

Abdel-Rahman SM, Bayıcı BZ, Keske Ş, Kuşkucu M, Özsürekçi Y, Rimoin AW, Rodriguez-Morales AJ, Ergönül Ö. Mpox primer for clinicians: what makes the difference in[...]

Pickering H, Schaenman J, Phan HV, Maguire C, Tsitsiklis A, Rouphael N, Higuita NIA, Atkinson MA, Brakenridge S, Fung M, Messer W; IMPACC Network; Salehi-Rad[...]

Tran PNT, Limothai U, Dinhuzen J, Tachaboon S, Sukmark T, Dokpong C, Roytrakul S, Haake DA, Srisawat N. MicroRNA Biomarkers and Host Response Pathways in[...]

Kinganda-Lusamaki E, Amuri-Aziza A, Fernandez-Nuñez N, Makangara-Cigolo JC, Pratt C, Vakaniaki EH, Hoff NA, Luakanda-Ndelemo G, Akil-Bandali P, Nundu SS, Mulopo-Mukanya N, Ngimba M, Modadra-Madakpa[...]

Thorp M, Phiri S, Phiri K, Robson I, Mphande M, Dovel K, Hoffman R. Brief Report: Stated Preferences for Long-Acting Injectable ART Among Mobile Men[...]

Chavez C, Lin K, Malveaux A, Gorin A, Brizuela S, Cheng QJ, Hoffmann A. IRF1 cooperates with ISGF3 or GAF to form innate immune de[...]

Ogawa L, Morinishi C, Multani A, Gaynor P, Beaird OE, Pham C, Schaenman JM. Real-World Comparison of Maribavir to Foscarnet for the Treatment of Cytomegalovirus[...]

Hernandez CJ, Sundar KG, Echegaray F, Cambou MC, Yang LZ, Segura ER, Gonçalves de Melo M, Santos BR, Varella IRDS, Nielsen-Saines K. The Benefits of[...]

Blair CS, Shoptaw SJ. Managing Stimulant Use Among People With HIV: Harm-Reduction Strategies From Behavior to Medication. Top Antivir Med. 2024 Dec 23;32(5):571-578. PMID: 39765236.